Buying stocks may not be your priority at the moment. The stock market's performance probably isn't inspiring you to drop everything and finish up the year with some investing, either. All three indexes slipped into bear market territory this year, and December often is a quiet month when it comes to corporate news. Read More...
TipRanks
Investing in These 2 Biotech Stocks Could Double Your Money, Says Analyst
Let’s talk about biotech. These stocks present a unique set of attractions for investors, especially investors willing to shoulder some extra risk. To start with, biotech firms have a famously high overhead, and equally long lead-times for product development. But that is balanced by the opportunity for huge gains – sales profits, and share appreciation – when a new drug shows strongly positive clinical trial results, or receives regulatory approval for commercialization. To give an example, jus
